MegazoneCloud Builds Quality Assurance AI Agent for Hanmi Pharmaceutical
MegazoneCloud is developing Hanmi Q-Agent to automate quality assurance operations at Hanmi Pharmaceutical, the company said in a press release. The system will run on MegazoneCloud's AIR Studio enterprise AI platform.
Hanmi Q-Agent will process about 4,000 quality documents. It will use retrieval augmented generation to find and summarize documents, compare them with current regulations, and identify items that do not comply. The project targets a reduction of more than 40 percent in related work time.
MegazoneCloud will fine tune Upstage's Korean Solar model for Hanmi Pharmaceutical's good manufacturing practice work. Samsung SDS will provide the project infrastructure, while Selectstar will handle data processing and third party verification.
The project is part of South Korea's MSIT and NIPA AX One Stop Voucher Program. The participating companies held a kickoff meeting on August 28, 2026.
We hope you enjoyed this article.
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from: Enterprise
More from: Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
Thomson Reuters
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more